|
CCDC121 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.31321645066873E-13 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.94655402907529E-12 |
| Normal-vs-Stage2 |
1.50679999588732E-08 |
| Normal-vs-Stage3 |
9.78772618509538E-13 |
| Normal-vs-Stage4 |
3.49269999999624E-06 |
| Stage1-vs-Stage2 |
3.560000E-01 |
| Stage1-vs-Stage3 |
3.346000E-01 |
| Stage1-vs-Stage4 |
8.313200E-01 |
| Stage2-vs-Stage3 |
1.068640E-01 |
| Stage2-vs-Stage4 |
5.340200E-01 |
| Stage3-vs-Stage4 |
8.356400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62458935193399E-12 |
| Normal-vs-AfricanAmerican |
3.46270000450843E-08 |
| Normal-vs-Asian |
1.73867999999633E-05 |
| Caucasian-vs-AfricanAmerican |
2.800600E-01 |
| Caucasian-vs-Asian |
7.015200E-01 |
| AfricanAmerican-vs-Asian |
5.456200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
4.00139998912863E-09 |
| Male-vs-Female |
2.011900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.73949990364986E-10 |
| Normal-vs-Extreme_Weight |
1.62436730732907E-12 |
| Normal-vs-Obese |
1.27909904890089E-11 |
| Normal-vs-Extreme_Obese |
2.970000E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.469960E-01 |
| Normal_Weight-vs-Obese |
8.256800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.204800E-01 |
| Extreme_Weight-vs-Obese |
1.944610E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.592800E-01 |
| Obese-vs-Extreme_Obese |
3.857600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.35160000028323E-07 |
| Normal-vs-Age(41-60Yrs) |
1.12569953358843E-11 |
| Normal-vs-Age(61-80Yrs) |
4.81836792687318E-14 |
| Normal-vs-Age(81-100Yrs) |
6.95470003808651E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.030800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.946850E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.420800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.455400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.416800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.665600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
1.79090076102284E-11 |
| Normal-VS-KIRP CIMP |
8.61249999983826E-07 |
| Normal-VS-Unclassified PRCC |
7.15659975725202E-10 |
| Type1 PRCC-VS-Type2 PRCC |
3.218400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.809200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.295410E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.983600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.151400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.174000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.81550000000197E-06 |
| Normal-vs-N2 |
8.04680000000557E-05 |
| N0-vs-N1 |
1.092810E-01 |
| N0-vs-N2 |
8.128000E-01 |
| N1-vs-N2 |
4.185400E-01 |
|
|
